John Slattery

CEO of BioROSA Technologies

What is your sense of purpose? How John Slattery, CEO of BioROSA Technologies is making the diagnosis of Autism Spectrum disorder (ASD) rapid and simple.

John Slattery, CEO of BioROSA Technologies, shares the story of why he is developing a highly accurate blood test that will detect Autism Spectrum disorder in children as young as 18 months.

Listen to John’s inspiring story of how finding a sense of purpose built the foundations, vision and passion that led to him creating a business that is positively impacting a large amount of change in the ASD population.

Over 30M children and over 100M+ people around the world are suffering from Autism Spectrum Disorders (ASD).  Back in the 70s and 80s, it was believed that autism affected 1 in 10,000 children in the US. Now the current estimate is 1 in 54 children in the US.

Let's talk

Get in touch with one of our
specialist consultants today.

Stay connected